Surgical Management of Renal Cell Carcinoma (RCC) with Vena Cava Tumour Thrombus

Emanuele Belgrano, Carlo Trombetta, Salvatore Siracusano, Giorgio Carmignani, Giuseppe Martorana, Giovanni Liguori

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives: Renal cell carcinoma (RCC) propagation into the inferior vena cava is rare (10-25%) and is described as an extension above the hepatic veins up to the right atrium or even into the right ventricle. Venous tumour invasion is associated with several prognostic factors such as local infiltration of perinephric tissue, lymph nodes metastases, caval infiltration, and the presence of distant metastases. We reviewed our experience with surgical treatment of RCC with vena cava involvement. Methods: We analysed the Urological Genoa School results from 1970 to 1985 on 28 consecutive cases (Giuliani's series) and between 1986 and 2005 on 59 of 81 cases from three Italian urologic academic centres (Trieste, Bologna, and Genoa). Results: For 1970-1985, the overall survival rate for all patients was 30% at follow-up periods of 36-66 mo. With caval infiltration, the overall survival rate at 12 mo was 0%. For the period 1986-2005, the overall survival rate at 8 yr was about 80%. Nonsignificant differences for nodal stage and caval infiltration were observed during the two time periods. Conclusions: Our data confirm, as reported by others, that nonmetastatic RCC with extension into vena cava is potentially curable.

Original languageEnglish
Pages (from-to)610-618
Number of pages9
JournalEuropean Urology, Supplements
Volume5
Issue number8
DOIs
Publication statusPublished - Jun 2006

Fingerprint

Venae Cavae
Renal Cell Carcinoma
Thrombosis
Survival Rate
Neoplasms
Neoplasm Metastasis
Hepatic Veins
Inferior Vena Cava
Heart Atria
Heart Ventricles
Lymph Nodes

Keywords

  • Renal cell carcinoma
  • Thrombus
  • Tumour invasion
  • Vena cava involvement

ASJC Scopus subject areas

  • Urology

Cite this

Belgrano, E., Trombetta, C., Siracusano, S., Carmignani, G., Martorana, G., & Liguori, G. (2006). Surgical Management of Renal Cell Carcinoma (RCC) with Vena Cava Tumour Thrombus. European Urology, Supplements, 5(8), 610-618. https://doi.org/10.1016/j.eursup.2006.04.001

Surgical Management of Renal Cell Carcinoma (RCC) with Vena Cava Tumour Thrombus. / Belgrano, Emanuele; Trombetta, Carlo; Siracusano, Salvatore; Carmignani, Giorgio; Martorana, Giuseppe; Liguori, Giovanni.

In: European Urology, Supplements, Vol. 5, No. 8, 06.2006, p. 610-618.

Research output: Contribution to journalArticle

Belgrano, E, Trombetta, C, Siracusano, S, Carmignani, G, Martorana, G & Liguori, G 2006, 'Surgical Management of Renal Cell Carcinoma (RCC) with Vena Cava Tumour Thrombus', European Urology, Supplements, vol. 5, no. 8, pp. 610-618. https://doi.org/10.1016/j.eursup.2006.04.001
Belgrano E, Trombetta C, Siracusano S, Carmignani G, Martorana G, Liguori G. Surgical Management of Renal Cell Carcinoma (RCC) with Vena Cava Tumour Thrombus. European Urology, Supplements. 2006 Jun;5(8):610-618. https://doi.org/10.1016/j.eursup.2006.04.001
Belgrano, Emanuele ; Trombetta, Carlo ; Siracusano, Salvatore ; Carmignani, Giorgio ; Martorana, Giuseppe ; Liguori, Giovanni. / Surgical Management of Renal Cell Carcinoma (RCC) with Vena Cava Tumour Thrombus. In: European Urology, Supplements. 2006 ; Vol. 5, No. 8. pp. 610-618.
@article{e73e4e681de74f77b4d5aeeaa8771e4d,
title = "Surgical Management of Renal Cell Carcinoma (RCC) with Vena Cava Tumour Thrombus",
abstract = "Objectives: Renal cell carcinoma (RCC) propagation into the inferior vena cava is rare (10-25{\%}) and is described as an extension above the hepatic veins up to the right atrium or even into the right ventricle. Venous tumour invasion is associated with several prognostic factors such as local infiltration of perinephric tissue, lymph nodes metastases, caval infiltration, and the presence of distant metastases. We reviewed our experience with surgical treatment of RCC with vena cava involvement. Methods: We analysed the Urological Genoa School results from 1970 to 1985 on 28 consecutive cases (Giuliani's series) and between 1986 and 2005 on 59 of 81 cases from three Italian urologic academic centres (Trieste, Bologna, and Genoa). Results: For 1970-1985, the overall survival rate for all patients was 30{\%} at follow-up periods of 36-66 mo. With caval infiltration, the overall survival rate at 12 mo was 0{\%}. For the period 1986-2005, the overall survival rate at 8 yr was about 80{\%}. Nonsignificant differences for nodal stage and caval infiltration were observed during the two time periods. Conclusions: Our data confirm, as reported by others, that nonmetastatic RCC with extension into vena cava is potentially curable.",
keywords = "Renal cell carcinoma, Thrombus, Tumour invasion, Vena cava involvement",
author = "Emanuele Belgrano and Carlo Trombetta and Salvatore Siracusano and Giorgio Carmignani and Giuseppe Martorana and Giovanni Liguori",
year = "2006",
month = "6",
doi = "10.1016/j.eursup.2006.04.001",
language = "English",
volume = "5",
pages = "610--618",
journal = "European Urology, Supplements",
issn = "1569-9056",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - Surgical Management of Renal Cell Carcinoma (RCC) with Vena Cava Tumour Thrombus

AU - Belgrano, Emanuele

AU - Trombetta, Carlo

AU - Siracusano, Salvatore

AU - Carmignani, Giorgio

AU - Martorana, Giuseppe

AU - Liguori, Giovanni

PY - 2006/6

Y1 - 2006/6

N2 - Objectives: Renal cell carcinoma (RCC) propagation into the inferior vena cava is rare (10-25%) and is described as an extension above the hepatic veins up to the right atrium or even into the right ventricle. Venous tumour invasion is associated with several prognostic factors such as local infiltration of perinephric tissue, lymph nodes metastases, caval infiltration, and the presence of distant metastases. We reviewed our experience with surgical treatment of RCC with vena cava involvement. Methods: We analysed the Urological Genoa School results from 1970 to 1985 on 28 consecutive cases (Giuliani's series) and between 1986 and 2005 on 59 of 81 cases from three Italian urologic academic centres (Trieste, Bologna, and Genoa). Results: For 1970-1985, the overall survival rate for all patients was 30% at follow-up periods of 36-66 mo. With caval infiltration, the overall survival rate at 12 mo was 0%. For the period 1986-2005, the overall survival rate at 8 yr was about 80%. Nonsignificant differences for nodal stage and caval infiltration were observed during the two time periods. Conclusions: Our data confirm, as reported by others, that nonmetastatic RCC with extension into vena cava is potentially curable.

AB - Objectives: Renal cell carcinoma (RCC) propagation into the inferior vena cava is rare (10-25%) and is described as an extension above the hepatic veins up to the right atrium or even into the right ventricle. Venous tumour invasion is associated with several prognostic factors such as local infiltration of perinephric tissue, lymph nodes metastases, caval infiltration, and the presence of distant metastases. We reviewed our experience with surgical treatment of RCC with vena cava involvement. Methods: We analysed the Urological Genoa School results from 1970 to 1985 on 28 consecutive cases (Giuliani's series) and between 1986 and 2005 on 59 of 81 cases from three Italian urologic academic centres (Trieste, Bologna, and Genoa). Results: For 1970-1985, the overall survival rate for all patients was 30% at follow-up periods of 36-66 mo. With caval infiltration, the overall survival rate at 12 mo was 0%. For the period 1986-2005, the overall survival rate at 8 yr was about 80%. Nonsignificant differences for nodal stage and caval infiltration were observed during the two time periods. Conclusions: Our data confirm, as reported by others, that nonmetastatic RCC with extension into vena cava is potentially curable.

KW - Renal cell carcinoma

KW - Thrombus

KW - Tumour invasion

KW - Vena cava involvement

UR - http://www.scopus.com/inward/record.url?scp=33646559960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646559960&partnerID=8YFLogxK

U2 - 10.1016/j.eursup.2006.04.001

DO - 10.1016/j.eursup.2006.04.001

M3 - Article

AN - SCOPUS:33646559960

VL - 5

SP - 610

EP - 618

JO - European Urology, Supplements

JF - European Urology, Supplements

SN - 1569-9056

IS - 8

ER -